Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for pat

• 作 者: Shanshan Qin Hui Yu Xianghua W
• 机 构: DepartmentofMedicalOncology
• 出 处: 中国癌症研究:英文版
• 发表日期: 2019年2期
• 关键词: Albumin-bound PACLITAXEL CISPLATIN GEMCITABINE FIRST-LINE therapy ADVANCED non-s

Objective: The aim of this trial was to compare both the efficacy and the safety of a weekly nanoparticle albumin-bound paclitaxel(nab-paclitaxel) plus cisplatin vs. gemcitabine plus cisplatin in patients with advanced non-small-cell lung cancer(NSCLC).Me